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Abstract
Background: Cytochrome P450 enzymes (P450s) have been implicated in insecticide resistance. Anopheles
minumus mosquito P450 isoforms CYP6AA3 and CYP6P7 are capable of metabolizing pyrethroid insecticides,
however CYP6P8 lacks activity against this class of compounds.
Findings: Homology models of the three An. minimus P450 enzymes were constructed using the multiple
template alignment method. The predicted enzyme model structures were compared and used for molecular
docking with insecticides and compared with results of in vitro enzymatic assays. The three model structures
comprise common P450 folds but differences in geometry of their active-site cavities and substrate access
channels are prominent. The CYP6AA3 model has a large active site allowing it to accommodate multiple
conformations of pyrethroids. The predicted CYP6P7 active site is more constrained and less accessible to binding
of pyrethroids. Moreover the predicted hydrophobic interface in the active-site cavities of CYP6AA3 and CYP6P7
may contribute to their substrate selectivity. The absence of CYP6P8 activity toward pyrethroids appears to be due
to its small substrate access channel and the presence of R114 and R216 that may prevent access of pyrethroids to
the enzyme heme center.
Conclusions: Differences in active site topologies among CYPAA3, CYP6P7, and CYP6P8 enzymes may impact
substrate binding and selectivity. Information obtained using homology models has the potential to enhance the
understanding of pyrethroid metabolism and detoxification mediated by P450 enzymes.
Findings
Insecticide resistance is a growing problem in the con-
trol of mosquito species that serve as vectors in the
spread of malaria. One of the major classes of insecti-
cide detoxification enzymes is the heme-containing cyto-
chrome P450 monooxygenases (P450s). These enzymes
are responsible for the metabolism of endogenous and
exogenous compounds and the expression of several
P450s is increased in insecticide resistant insects [1].
P450 enzymes are thought to promote resistance due to
their ability to metabolize insecticidal compounds [2-5]
however, the link between increased expression of P450s
and insecticide resistance has not been clearly estab-
lished. Structural information on insect P450s together
with investigation of their function in insecticide meta-
bolism may help to increase the understanding of their
roles in insecticide detoxification and resistance. To
date, crystal structures of insect P450s have not been
resolved and structural studies relying on in silico
homology modeling approaches have been used to gain
insight into the molecular basis of insecticide binding
[2,6,7].
We previously observed elevated expression of P450
isoforms CYP6AA3, CYP6P7,a n dCYP6P8 in a labora-
tory-selected deltamethrin-resistant An. minimus mos-
quito, a major malaria vector in Thailand, relative to the
parent susceptible strain [8]. The increase in CYP6AA3
and CYP6P7 transcripts correlated with increased
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enhance resistance to deltamethrin. Our results are con-
sistent with the known overlapping metabolic profiles of
CYP6AA3 and CYP6P7 against type I and II pyrethroids
[5]. The homology between CYP6P7 to CYP6P8 (61%
amino acid identity) does not support a role for CYP6P8
in pyrethroid metabolism [5]. In this study, homology
modeling of An. minimus CYP6AA3, CYP6P7, and
CYP6P8 enzymes was conducted and molecular docking
was performed with various insecticide compounds. Our
analysis was able to predict the molecular basis of P450
activity against pyrethroid compounds and has the
potential to assist in the investigation of new com-
pounds that can bypass resistance due to P450 enzymes.
Methods
Amino acid sequences of CYP6AA3 (GenBank:
AAN05727.1), CYP6P7 (GenBank: AAR88141.1), and
CYP6P8 (GenBank: AAR88142.1) were aligned against
protein structures deposited in Brookhaven Protein Data
Bank (PDB) [9] using PSI-BLAST. Crystal structures of
ligand-free CYP3A4 (PDB: 1TQN) [10], CYP2C8 (PDB:
1PQ2) [11], and CYP2C9 (PDB: 1OG2) [12] were used
as templates since their sequences were most similar to
the target P450s (14-33% primary sequence identity).
The templates structures do not contain residues in N-
terminal membrane-binding domain and thus the first
25 residues at the N-termini of the three target P450s
were not included in model construction (see Additional
files 1 and 2 for sequence alignment and percent
sequence identity).
Comparative modeling of CYP6AA3, CYP6P7, and
CYP6P8 was performed using a restrained-based
approach implemented in MODELLER9v6 [13]. Multiple
amino acid sequence alignment of CYP3A4, CYP2C8,
and CYP2C9 template structures was performed using
t h eS A L I G Nm o d u l ei nM O D E L L E R 9 v 6 ,a n ds u b s e -
quently aligned individually with target enzymes. A set
of 1000 models for each target enzyme was constructed.
The coordinates of heme in the models were obtained
from CYP3A4 (1TQN) and positioned in targets as in
the 1TQN template. The resulting three-dimensional
models of CYP6AA3, CYP6P7, and CYP6P8 were sorted
according to scores calculated from discrete optimized
protein energy (DOPE) scoring function [14]. The
knowledge-based conditional probabilities for the resi-
due specific all-atom probability discriminatory function
(RAPDF) in RAMP suite was used to discriminate native
structures from incorrectly-folded structures [15].
Refinement of models was performed using Amber10
package [16] to reduce steric clashes among residues.
The AMBER ff03 all atom force field was applied. The
proteins were solvated in TIP3P water molecules with
12 Å cutoff. Solvent was relaxed while backbone atoms
were kept restrained for 100 steps of steepest decent fol-
l o w e db y2 0 0s t e p so fc o n j u g a t e dg r a d i e n t .S u b s e -
quently, all atoms were allowed to move freely without
any restraint until energy gradient was < 0.05 kcal/mol.
The refined models were determined for distribution of
phi and psi angles using ProSAII [17,18] and Procheck
[19].
Three-dimensional structures of pyrethroids (perme-
thrin, bioallethrin, cypermethrin, deltamethrin, and l-
cyhalothrin), alongside organophosphate (chlorpyrifos),
and carbamate (propoxur) shown in Additional file 3
were obtained from ChemIDplus database http://chem.
sis.nlm.nih.gov/chemidplus/ and used in docking of
three target models. Partial charges of ligands and pro-
teins were generated using Gasteiger method with the
aid of AutoDockTools [20]. Restrained electrostatic
potential atomic charge method described by Oda et al.
[21] was used to assign high-spin state of five-coordi-
nated ferrous heme complex to simulate substrate bind-
ing state. In addition, oxyferryl state was assigned to
heme group of target models following Seifert et al. [22]
to compare modes of substrate binding at different
heme states. A cubic grid having 60 × 60 × 60 grid
points per side and spacing of 0.375 Å was set corre-
sponding to substrate recognition sites (SRSs) of each
mosquito P450 model following those of CYP2 family
proposed by Gotoh [23]. The second grid was posi-
tioned onto substrate access channels extending into
binding pocket of individual model. Affinity maps of
grids were calculated using AutoGrid program. Auto-
Dock 4.0 program [24] was employed to dock ligands
into active-site cavity of target models using Lamarckian
genetic algorithm, consisting of 200 runs and 270000
generations, with the maximum number of energy eva-
luation set to 2.5 × 10
6. Resulting docked conformations
within 2.0 Å root mean square deviation (RMSD) toler-
ance were clustered and analyzed using AutoDockTools.
Conformations with the lowest interaction energy and
closest interaction to heme iron were selected. Residues
showing interaction with docked ligands with less than
1.0 scaling factor of van der Waal radii were deter-
mined. Active sites and substrate access channels of
enzyme models were calculated using the VOIDOO pro-
gram [25] with conventional probe radius of 1.4 Å.
Molecular visualization was performed on PyMOL 0.93
(Schrödinger, LLC).
Results and Discussion
Homology models of CYP6AA3, CYP6P7 and CYP6P8
were constructed based on crystal structures of
CYP3A4, CYP2C8, and CYP2C9 human P450s that are
involved in pyrethroid metabolism [26] using the multi-
p l es e q u e n c ea l i g n m e n ts t r a t egy. Candidate predicted
models of three mosquito P450s were selected based on
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that discriminate native structures from those misfolded.
CYP6AA3, CYP6P7, and CYP6P8 models have overall
ProSA z-scores of -8.24, -7.39, and -8.09, respectively.
Ramachandran plot analyses of CYP6AA3, CYP6P7 and
CYP6P8 models reveal 1.6%, 1.2% and 0.5% of the resi-
dues, respectively, located in disallowed regions. ProSA
z-scores and Ramachandran plot analyses indicate that
the three models are all of reasonable quality.
Overall conserved P450 folds are found in the three
P450 models (Figure 1), such as helices D, E, I, J, K and
L, and cysteine-pocket attaching heme. Structural differ-
ences between human and mosquito P450s are attribu-
ted to SRSs (Figure 2) spanning access channels and
active sites of enzymes. Among the mosquito models,
differences in substrate access channels and geometry of
predicted active sites are apparent. Searching for possi-
ble substrate access channels revealed a surface channel
opening in CYP6AA3, designated pw2c following a pre-
vious report [27], located between B
//C loop, C-termi-
nus of G-helix and N-terminus of I-helix. The putative
CYP6P7 pw2b access channel is comprised of residues
from B/B
/loop and b1 sheet, while pw2e is observed in
BC loop/B
/helix and N-terminus of I-helix of CYP6P8
model. Differences in the geometry of the predicted
active sites is remarkable with CYP6AA3 having an oval
shape and a large volume, 245.69 Å
3 in size (Figure 3A),
while CYP6P7 has a restrained narrow opening to the
heme prosthetic group and is smaller (volume of 135.11
Å
3, Figure 3B). The CYP6P8 active site has the smallest
volume, 68.13 Å
3, attributed to protrusion of guanidino
group of R216, and R114 is perpendicular to the channel
opening (Figure 3C).
We have reported that CYP6AA3 and CYP6P7 can
metabolize pyrethroids (permethrin, cypermethrin, and
deltamethrin), but lacked activity against bioallethrin
(pyrethroid), chlorpyrifos (organophosphate), and pro-
poxur (carbamate) [5]. Notably CYP6AA3 contains l-
cyhalothrin (pyrethroid) degradation activity while
CYP6P7 cannot metabolize this compound [5]. To com-
pare the model structures of CYP6AA3, CYP6P7, and
CYP6P8 with regard to their metabolic activities, pyre-
throids were docked onto these models. In CYP6AA3,
the large substrate channel allows passage of multiple
conformations of pyrethroids to fit in active-site cavity,
while CYP6P7 provides more restricted access of pyre-
throids allowing one or two conformations to fit within
the cavity (Table 1). Figure 4 shows an example of the
predicted binding of deltamethrin, with multiple confor-
mations, to the CYP6AA3 active site (Figure 4A-D) and
a single deltamethrin conformation bound to CYP6P7
(Figure 4E). As such, it can be anticipated that
Figure 1 Overall fold and overlay of homology models of CYP6AA3 (green), CYP6P7 (purple), and CYP6P8 (magenta). Model structures
are shown in top (A) and back (B) views. Secondary structures of helices A-L and sheets b1-4 are labeled. The heme group in the middle of the
structure is represented by stick.
Figure 2 Predicted substrate recognition sites (SRSs).S R S sa r e
colored and designated 1-6 on homology model of CYP6AA3.
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potential to generate multiple metabolites according to
the position of pyrethroids (geminal dimethyl group, 5-
and 4
/-phenoxybenzyl carbons, and alpha carbon at
cyano group) attacked by the enzyme. This prediction is
in agreement with our results showing multiple pro-
ducts from CYP6AA3-mediated deltamethrin degrada-
tion [28]. Multiple products have also been detected
from pyrethroid metabolism mediated by insect and
rodent P450s [4,29-31]. To test whether the binding of
insecticides would be altered in different heme states of
P450s, the oxyferryl state was simulated in CYP6AA3
and CYP6P7 and docked with deltamethrin. Our results
indicate that the docked pyrethroid conformations on
the iron-oxo enzyme complex (Additional file 4) are
similar to those obtained from high-spin ferrous state
(Figure 4), emphasizing the significance of enzyme
active-site geometry to influence substrate selectivity
and the conformation of substrate binding regardless of
the heme state in the enzymes.
Compared to CYP6AA3, CYP6P7 possesses a narrow
channel opening to heme iron, resulting in structural
constraint toward pyrethroids and limited access to l-
cyhalothrin. The phenoxybenzyl moiety of pyrethroids is
predicted to be a favorable attack site for CYP6P7
(Table 1). Moreover the bulky trifluoromethyl group
(Additional file 3) causes the 4
/-phenoxybenzyl carbon
of l-cyhalothrin moving away from the CYP6P7 heme
( 4 . 1 7Å )c o m p a r e dt ot h a to fc y p e r m e t h r i n( 3 . 3 1Å ,
Table 1), and thus the trifluoromethyl group may be
responsible for absence of detectable CYP6P7 activity
against l-cyhalothrin [5]. Analogous findings have been
shown for a CYP6B8v1 predicted model that contains a
narrow active-site cavity, leading to its ability to metabo-
lize only small flexible molecules but not large rigid
molecules [7].
Residues in the CYP6AA3 cavity that interact with pyr-
ethroids in our docking experiments (Table 1) are gener-
ally non-polar, implying that binding may occur via
hydrophobic interactions with non-polar pyrethroids that
have octanol-water partition coefficient (log P)v a l u e s
ranging from 6.2-6.8. Since bioallethrin, chlorpyrifos, and
propoxur (values of 4.78, 4.96, and 1.52 respectively) are
more polar, they would be expected to have less favorable
interactions with the active sites of CYP6AA3 and
CYP6P7 resulting in a longer distance between these
molecules and the heme iron (unpublished data). As a
result both CYP6AA3 and CYP6P7 are predicted to be
incapable of metabolizing bioallethrin, chlorpyrifos, and
propoxur, consistent with our previous results [5]. Bind-
ing of thiodicarb (carbamate, log P of 1.62), temephos,
and fenitrothion (organophosphates, log P of 5.96 and
3.3, respectively) to both of these enzymes is also pre-
dicted to be unfavorable (unpublished data).
In the CYP6P8 model, the small access channel
together with R114 and R216 are predicted to obstruct
pyrethroid entry into the active-site cavity (Figure 5),
resulting in the absence of CYP6P8 activity toward pyre-
throid [5]. Equivalent R114 and R216 residues are not
found in CYP6AA3 and CYP6P7 active sites and no such
hindrance of pyrethroid access is predicted. The presence
of the positively charged guanidino group of R114, specu-
lated to form hydrogen bond with the oxygen on ester of
pyrethroid, and R216 lying in narrow path (6.75 Å-width
Figure 3 Predicted active sites extending to enzyme surface of CYP6AA3 (A), CYP6P7 (B), and CYP6P8 (C). Active sites were calculated
using VOIDOO. I-helices of CYP6AA3 (gold), CYP6P7 (silver), and CYP6P8 (magenta) are depicted in cartoon, spanning across heme. Caption in
each figure corresponds to molecular surface view of each access channel. CYP6AA3 and CYP6P7 both display an oval shape of access opening,
while CYP6P8 has a relatively small circular pore. The R114 guanidino group is shown projected horizontally to the opening of the CYP6P8
channel. Carbon atoms in caption are colored separately on each structure, oxygen and nitrogen atoms are shown in red and blue, respectively.
The heme group in the middle of the structure is represented by red stick.
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Enzymes and
insecticides
a
Binding
sites
b
Estimate free
energy (kcal/mol)
Distance from
heme iron (Å)
c
Predicted contact residues
d
CYP6AA3
Permethrin Gem -7.31 3.26 (P217)
2, R220, (F309, A310, T314)
4, T317, (P375, V376)
5, (M491)
6
C5-PB -8.18 3.03 (H120)
1, (V306, F309, A310, E313, T314)
4, (P375)
5, (L492)
6
C4
/-PB -7.86 3.97 (E112, P116, H120, F122)
1, (F305, F309, A310, T314)
4, (V376, I380)
5
Cypermethrin Gem -9.10 3.01 (E112, P116, H120)
1, (R220)
2, (F309, A310, T314)
4, (I380, R381)
5
C5-PB -9.6 3.14 (F122)
1, (A310, T314)
4, (P375, V376, P377, R381)
5, (M491, L492)
6
C4
/-PB -9.64 4.38 (E112, H120, F122)
1, (V306, F309, A310, T314)
4, (V376, I380, R381, V382)
5
CN -9.41 4.09 (H120, F122)
1, (V306, F309, A310, T314)
4, (P375, V376)
5, (L492)
6
Deltamethrin Gem -8.50 3.45 (E112, H120, F122)
1, (A310, E313, T314)
4, (P375, V376, I380, R381)
5, (M491)
6
C5-PB -8.66 3.31 (H120, F122)
1, (F309, A310, T314)
4, (V376, Q378, I380, R381)
5
C4
/-PB -8.52 3.49 (F122)
1, (A310, T314)
4, (P375, V376, I380, R381, V382)
5, (M491, L492)
6
CN -8.74 4.35 (H120, F122)
1, (F309, A310, T314)
4, (P375, V376, P377, Q378, I380, R381)
5
l-cyhalothrin Gem -7.90 3.31 (H120, F122)
1, (P217, N221)
2, (F309, A310, T314)
4, (P375, V376)
5, (M491, L492)
6
C5-PB -6.94 3.82 (H120, F122)
1, (T314)
4, (V376, R381)
5
C4
/-PB -7.65 3.02 (Y109, E112)
1, (R220)
2, (F309, A310, T314)
4, (P375, V376, I380, R381)
5
CN -7.89 3.51 (H120, F122)
1, (V306, F309, A310, E313, T314)
4, T317, (P375, V376, I380)
5,( L 4 9 2 )
6
CYP6P7
Permethrin C5-PB -6.45 3.35 (L313, A314, E317, T318)
4, (L380, E381, S382, I383, R385)
5, (F494, I495)
6
Cypermethrin Gem -8.92 3.52 (F110, F123)
1, (T220)
2, (L313, A314, T318)
4, (E381, R385)
5, (F494)
6
C4
/-PB -9.50 3.31 (L313, A314, E317, T318)
4, (L380, E381, S382, I383, R385)
5, (F494, I495)
6
Deltamethrin C4
/-PB -8.17 3.53 (F123)
1, (T220)
2, (A314, T318)
4, (L380, E381, R385)
5, (F494, I495, L496)
6
l-cyhalothrin C4
/-PB -8.52 4.17 (E317, T318)
4, T321, (L380, E381, S382, R385)
5, (I495, L496)
6
aChemical structures of insecticides are shown in Additional file 3.
bPredicted metabolic sites are indicated as following: Gem, geminal-dimethyl group in acid moiety; C5-PB, carbon 5 of phenoxybenzyl group in alcohol moiety;
C4
/-PB, carbon 4
/of phenoxybenzyl group in alcohol moiety; and CN, cyano group.
cDistances between the heme iron and putative metabolic sites are measured.
dResidues are grouped based on substrate recognition sites (SRSs) in parentheses. Superscript represents order of SRS.
Figure 4 Deltamethrin binding modes in active sites of CYP6AA3 (A-D) and CYP6P7 (E).C Y P 6 A A 3e x h i b i t e d4b i n d i n gm o d e so f
deltamethrin positioning close to heme iron: geminal-dimethyl group (A), 5-phenoxybenzyl carbon (B), 4
/-phenoxybenzyl carbon (C), and cyano
group (D). Single binding mode of deltamethrin in CYP6P7 was obtained with 4
/-phenoxybenzyl carbon as a predicted hydroxylation site (E).
Same color is applied for heme and all elements as in Figure 3.
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passing through the CYP6P8 channel opening (Figure
5B). A similar situation has been observed in protein
kinase C, where mutation of amino acids to arginine resi-
dues in the C1 domain binding cleft can significantly
reduce interaction and membrane translocation of phor-
bol 12,13-dibutyrate [32]. It is possible that the topology
and residues within the CYP6P8 active site might not
favorably allow entry of arene compounds such as pyre-
throids to the heme center, but may allow entry of small
hydrocarbon compounds. Further investigation of
CYP6P8-mediated metabolism may reveal its preferred
substrates.
Conclusion
The model structures of CYP6AA3, CYP6P7, and
CYP6P8 generated in this study have allowed us to bet-
ter understand the different substrate preferences
between these P450 enzymes and the predictions based
on our docking studies are consistent with experimental
results of pyrethroid metabolism mediated by these
three enzymes. Variations in the predicted substrate
channels and geometry of active sites appear to be
responsible for their differences in binding to pyre-
throids. Our findings indicate that differences in meta-
bolic activities among P450 enzymes in insects can be
attributed to structural differences that allows for selec-
tivity in their activities against insecticides. These mod-
els have the potential to be used in the investigation of
candidate P450 inhibitors or in the analysis of the bind-
ing and metabolism of insecticide compounds that have
potential for use in the control of the mosquito vector.
Additional material
Additional file 1: Figure S1. Multiple sequence alignment of templates
and target P450s. Template sequences of CYP3A4 (1TQN chain A),
CYP2C9 (1OG2 chain A) and CYP2C8 (1PQN chain A) are aligned against
target sequences CYP6AA3, CYP6P7 and CYP6P8. The first 25 residues on
N-termini of target sequences are underlined and bolded. Residues
mostly identical among templates and targets are marked yellow.
Identical residues among all sequences are indicated by asterisks and
yellow mark. Residues of target identical to CYP3A4 template are marked
grey, whereas target residues identical to CYP2Cs are marked green.
Predicted contact residues between targets and ligands are marked blue.
Protruding arginine at the entry of substrate access channel in CYP6P8
model is highlighted red and arginine and phenylalanine in the channel
are in violet. CYP6AA3 primary sequence comprises 505 residues, CYP6P7
509 residues and CYP6P8 506 residues.
Additional file 2: Table. Percent amino acid sequence similarity
between crystallographic templates and target sequences.
Additional file 3: Figure S2. Insecticides used in docking study.
Pyrethroids shown are cypermethrin (A), permethrin (B), deltamethrin (C)
and l-cyhalothrin (D). Non-substrate insecticides docked in this study are:
propoxur, a type of carbamate insecticide (E); chlorpyrifos, a type of
organophosphate insecticide (F); and bioallethrin pyrethroid insecticide
(G). Geminal-dimethyl group, 5- and 4
/-phenoxybenzyl carbons are
indicated by arrows on cypermethrin.
Additional file 4: Figure S3. Docked deltamethrin conformations in
oxyferryl state of CYP6AA3 (A-D) and CYP6P7 (E). Predicted metabolic
sites are at geminal dimethyl group (A), 5-phenoxybenzyl carbon (B), 4
/-
phenoxybenzyl carbon (C), cyano group (D), and 4
/-phenoxybenzyl
carbon in CYP6P7 (E). Helices I of CYP6AA3 and CYP6P7 are shown in
gold and silver cartoons, respectively. Oxyferryl heme is represented by
grey stick, while deltamethrin is illustrated in green stick. Iron, oxygen,
and nitrogen are colored orange, red, and blue, respectively.
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